Based on the reduced blood glucose and insulin levels in Npgl-overexpressing HFD-fed mice at the experimental end point, we propose that NPGL prevents HFD-induced glucose intolerance, insulin resistance, and hyperglycemia in mice. The gene discussed is INS; the disease is Insulin resistance.